The DOI matches its Crossref record; 73 of the 76 references it cites were found in a registry or an index.
Gene expression profiling in the adult Down syndrome brain
Open accessAbstract
The mechanisms by which trisomy 21 leads to the characteristic Down syndrome (DS) phenotype are unclear. We used whole genome microarrays to characterize for the first time the transcriptome of human adult brain tissue (dorsolateral prefrontal cortex) from seven DS subjects and eight controls. These data were coanalyzed with a publicly available dataset from fetal DS tissue and functional profiling was performed to identify the biological processes central to DS and those that may be related to late onset pathologies, particularly Alzheimer disease neuropathology. A total of 685 probe sets were differentially expressed between adult DS and control brains at a stringent significance threshold (adjusted p value (q) < 0.005), 70% of these being up-regulated in DS. Over 25% of genes on chromosome 21 were differentially expressed in comparison to a median of 4.4% for all chromosomes. The unique profile of up-regulation on chromosome 21, consistent with primary dosage effects, was accompanied by widespread transcriptional disruption. The critical Alzheimer disease gene, APP, located on chromosome 21, was not found to be up-regulated in adult brain by microarray or QPCR analysis. However, numerous other genes functionally linked to APP processing were dysregulated. Functional profiling of genes dysregulated in both fetal and adult datasets identified categories including development (notably Notch signaling and Dlx family genes), lipid transport, and cellular proliferation. In the adult brain these processes were concomitant with cytoskeletal regulation and vesicle trafficking categories, and increased immune response and oxidative stress response, which are likely linked to the development of Alzheimer pathology in individuals with DS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While several reports have investigated gene expression in postmortem human DS brains or derived pluripotent stem cells (Letourneau et al., 2014; Lockstone et al., 2007; Mao et al., 2003, 2005), these studies are limited by sparse genome coverage, numbers of samples or developmental time points, and potential variances between in vitro and in vivo gene regulation.”
From Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination (2016) · cites this paper as Lockstone et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Together, these studies demonstrate that many genes throughout the genome are altered in DS, confirming and extending previous findings that non-HSA21 genes may contribute significantly to trisomy 21 phenotypes (Letourneau et al., 2014; Lockstone et al., 2007).”
From Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination (2016) · cites this paper as Lockstone et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Quantification of both mRNA and protein levels in brains of individuals with DS from fetal to adult stages have shown that not all trisomic genes are dysregulated or expressed at 1.5-fold (Lockstone et al., 2007; Mao et al., 2005; Mao et al., 2003).”
From Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model (2024) · cites this paper as Lockstone et al., 2007
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Importantly, a growing body of evidence indicates that mutations in subunits of the SNX17-Retriever-CCC-WASH recycling pathway are involved in human pathologies primarily affecting the nervous system.”
From Recruitment of the SNX17-Retriever recycling pathway regulates synaptic function and plasticity (2023) · cites this paper as Lockstone et al., 2007
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
limma: Linear Models for Microarray Data
Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796
Genome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572
Bioinformatics and Computational Biology Solutions Using R and Bioconductor
Gentleman, R. C., Carey, V. J., Huber, W. K., Irizarry, R. A., & Dudoit, S. (2005) · Statistics in the health sciences · doi:10.1007/0-387-29362-0 · Cited by 3,470
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Flagged first, then by citations
3 of the 76 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Draghici, 2003, Global functional profiling of gene expression, Genomics, 81, 98
Cited by
Sorted by citations
Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders
Seidlitz, J., Nadig, A., Liu, S., Bethlehem, R. A. I., Vértes, P. E., Morgan, S. E., Váša, F., Romero-García, R., Lalonde, F. M., CLASEN, L. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17051-5 · Cited by 349
Domains of genome-wide gene expression dysregulation in Down’s syndrome
Letourneau, A., Santoni, F. A., Bonilla, X., Sailani, M. R., Gonzalez, D., Kind, J., Chevalier, C., Thurman, R., Sandstrom, R. S., Hibaoui, Y., et al. (2014) · Nature · doi:10.1038/nature13200 · Cited by 319
Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases
Migliore, L., & Coppedè, F. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.10.011 · Cited by 331
Cellular Senescence in Neurodegenerative Diseases
Martínez‐Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 299
Molecular genetic analysis of Down syndrome
Patterson, D. (2009) · Human Genetics · doi:10.1007/s00439-009-0696-8 · Cited by 278
Olmos-Serrano, J. L., Kang, H. J., Tyler, W. A., Silbereis, J. C., Cheng, F., Zhu, Y., Pletikos, M., Jankovic-Rapan, L., Cramer, N. P., Galdzicki, Z., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.042 · Cited by 239
“…Fig- ure S5B), neuronal differentiation (M4 and M45; Figures S6A and S6D), synaptic transmission and regulation (M10 and M34; Figures S6B and S6C), and electron transport (M14) (Table S6; Bahn et al., 2002; Lockstone et al., 2007; Sahún et al., 2014; Yoshida et al., 2013; Zampieri et al., 2014).”
Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway
Killick, R., Ribe, E. M., Al-Shawi, R., Malik, B., Hooper, C., Fernandes, C., Dobson, R., Nolan, P. M., Lourdusamy, A., Furney, S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2012.163 · Cited by 222
Neurological phenotypes for Down syndrome across the life span
Lott, I. T. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-54299-1.00006-6 · Cited by 225
The diverse consequences of aneuploidy
Chunduri, N. K., & Štorchová, Z. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0243-8 · Cited by 220
The importance of understanding individual differences in Down syndrome
Karmiloff‐Smith, A., Al‐Janabi, T., D’Souza, H., Groet, J., Massand, E., Mok, K. Y., Startin, C. M., Fisher, E., Hardy, J., Nižetić, D., et al. (2016) · F1000Research · doi:10.12688/f1000research.7506.1 · Cited by 214
New windows into the brain: Central nervous system-derived extracellular vesicles in blood
Shi, M., Sheng, L., Stewart, T., Zabetian, C. P., & Zhang, J. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.005 · Cited by 181
Briggs, J. A., Sun, J., Shepherd, J., Ovchinnikov, D. A., Chung, T.-L., Nayler, S. P., Kao, L.-P., Morrow, C. A., Thakar, N. Y., Soo, S.-Y., et al. (2013) · Stem Cells · doi:10.1002/stem.1297 · Cited by 151
Systematic proteome and proteostasis profiling in human trisomy 21 fibroblast cells
Liu, Y., Borel, C., Li, L., Müller, T., Williams, E. G., Germain, P.-L., Buljan, M., Sajic, T., Boersema, P. J., Shao, W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01422-6 · Cited by 141
Chromatin-wide Profiling of DYRK1A Reveals a Role as a Gene-Specific RNA Polymerase II CTD Kinase
Vona, C. D., Bezdan, D., Islam, A. B. M. M. K., Salichs, E., López-Bigas, N., Ossowski, S., & de la Luna, S. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.026 · Cited by 138
Pinto, B., Morelli, G., Rastogi, M., Savardi, A., Fumagalli, A., Petretto, A., Bartolucci, M., Varea, E., Catelani, T., Contestabile, A., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.010 · Cited by 135
Vilardell, M., Rasche, A., Thormann, A., Maschke-Dutz, E., Jurado, L. A. P., Lehrach, H., & Herwig, R. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-229 · Cited by 137
Kadota, K., Nakai, Y., & Shimizu, K. (2008) · Algorithms for Molecular Biology · doi:10.1186/1748-7188-3-8 · Cited by 119
Slonim, D. K., Koide, K., Johnson, K. L., Tantravahi, U., Cowan, J. M., Jarrah, Z., & Bianchi, D. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903909106 · Cited by 117
Neurogenesis impairment: An early developmental defect in Down syndrome
Stagni, F., Giacomini, A., Emili, M., Guidi, S., & Bartesaghi, R. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.026 · Cited by 120
Haematopoietic development and leukaemia in D own syndrome
Roberts, I. A. G., & Izraeli, S. (2014) · British Journal of Haematology · doi:10.1111/bjh.13096 · Cited by 111
Genome-wide expression studies in Autism spectrum disorder, Rett syndrome, and Down syndrome
Lintas, C., Sacco, R., & Persico, A. M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.010 · Cited by 96
Over-Expression of DSCAM and COL6A2 Cooperatively Generates Congenital Heart Defects
Grossman, T. R., Gamliel, A., Wessells, R. J., Taghli-Lamallem, O., Jepsen, K., Ocorr, K. A., Korenberg, J. R., Peterson, K. L., Rosenfeld, M. G., Bodmer, R., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002344 · Cited by 93
Silencing Trisomy 21 with XIST in Neural Stem Cells Promotes Neuronal Differentiation
Czerminski, J. T., & Lawrence, J. B. (2020) · Developmental Cell · doi:10.1016/j.devcel.2019.12.015 · Cited by 95
The Retromer Complex and Sorting Nexins in Neurodegenerative Diseases
Zhang, H., Huang, T. Y., Hong, Y., Yang, W., Zhang, X., Luo, H., Xu, H., & Wang, X. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00079 · Cited by 92
Hargis, K. E., & Blalock, E. M. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.007 · Cited by 90
Di Domenico, F., Tramutola, A., Foppoli, C., Head, E., Perluigi, M., & Butterfield, D. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.009 · Cited by 89
Down syndrome: Neurobiological alterations and therapeutic targets
Vacca, R. A., Bawari, S., Valenti, D., Tewari, D., Nabavi, S. F., Shirooie, S., Sah, A. N., Volpicella, M., Braidy, N., & Nabavi, S. M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.01.001 · Cited by 98
Altered cell and RNA isoform diversity in aging Down syndrome brains
Palmer, C. R., Liu, C. S., Romanow, W. J., Lee, M.-H., & Chun, J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114326118 · Cited by 89
Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A
Fernandez-Martinez, J., Vela, E. M., Tora-Ponsioen, M., Ocaña, O. H., Nieto, M., & Galceran, J. (2009) · Journal of Cell Science · doi:10.1242/jcs.044354 · Cited by 81
Choi, J. H. K., Berger, J. D., Mazzella, M. J., Morales‐Corraliza, J., Cataldo, A. M., Nixon, R. A., Ginsberg, S. D., Levy, E., & Mathews, P. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06277.x · Cited by 83
Yim, A., Koti, P. S., Bonnard, A., Marchianò, F., Dürrbaum, M., García-Pérez, C., Villaveces, J. M., Gamal, S., Cardone, G., Perocchi, F., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1128 · Cited by 75
Bhattacharyya, A., McMillan, E., Chen, S. I., Wallace, K., & Svendsen, C. N. (2009) · Developmental Neuroscience · doi:10.1159/000236899 · Cited by 79
Sheng, L., Leshchyns’ka, I., & Sytnyk, V. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1714-14.2015 · Cited by 74
Simone, R. D., Salas‐Puig, X., Gélisse, P., Crespel, A., & Genton, P. (2010) · Seizure · doi:10.1016/j.seizure.2010.04.008 · Cited by 69
Domenico, F. D., Tramutola, A., Barone, E., Lanzillotta, C., Defever, O., Arena, A., Zuliani, I., Foppoli, C., Iavarone, F., Vincenzoni, F., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101162 · Cited by 69
Williams, G. H. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-12 · Cited by 64
Martini, A. C., Helman, A. M., McCarty, K. L., Lott, I. T., Doran, E., Schmitt, F. A., & Head, E. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12113 · Cited by 66
Prenatal treatment of Down syndrome
Guedj, F., Bianchi, D. W., & Delabar, J. M. (2014) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000056 · Cited by 62
Schneider, P., Bayo, J., Singh, R. K., Dhanyamraju, P. K., Holz, P. S., Baier, A., Fendrich, V., Ramaswamy, A., Baumeister, S., Martínez, E. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9023 · Cited by 65
Age-Related Neurodegeneration and Memory Loss in Down Syndrome
Lockrow, J. P., Fortress, A. M., & Granholm, A. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/463909 · Cited by 68
Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression
Mowery, C. T., Reyes, J. M., Cabal‐Hierro, L., Higby, K. J., Karlin, K. L., Wang, J. H., Kimmerling, R. J., Cejas, P., Lim, K., Li, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.061 · Cited by 65
Grayson, B. L., Wang, L., & Aune, T. M. (2011) · Genes and Immunity · doi:10.1038/gene.2011.13 · Cited by 62
The burden of trisomy 21 disrupts the proteostasis network in Down syndrome
Aivazidis, S., Coughlan, C. M., Rauniyar, A. K., Jiang, H. L., Liggett, L. A., Maclean, K. N., & Roede, J. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176307 · Cited by 62
Integrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells
Pelleri, M. C., Cattani, C., Vitale, L., Antonaros, F., Strippoli, P., Locatelli, C., Cocchi, G., Piovesan, A., & Caracausi, M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00125 · Cited by 61
Guedj, F., Pennings, J. L. A., Massingham, L. J., Wick, H. C., Siegel, A. E., Tantravahi, U., & Bianchi, D. W. (2016) · Scientific Reports · doi:10.1038/srep32353 · Cited by 63
Sobol, M., Klar, J., Laan, L., Shahsavani, M., Schuster, J., Annerén, G., Konzer, A., Mi, J., Bergquist, J., Nordlund, J., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1585-3 · Cited by 61
Altered regulation of tau phosphorylation in a mouse model of down syndrome aging
Sheppard, O., Plattner, F., Rubin, A. N., Slender, A., Linehan, J. M., Brandner, S., Tybulewicz, V. L. J., Fisher, E., & Wiseman, F. K. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.025 · Cited by 55
Metabolomic analysis for first-trimester Down syndrome prediction
Bahado-Singh, R. O., Akolekar, R., Mandal, R., Dong, E., Xia, J., Kruger, M. L., Wishart, D. S., & Nicolaides, K. H. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.12.035 · Cited by 56
Laffaire, J., Rivals, I., Dauphinot, L., Pasteau, F., Wehrlé, R., Larrat, B., Vitalis, T., Moldrich, R. X., Rossier, J., Sinkus, R., et al. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-138 · Cited by 56
Proteome-wide discovery of mislocated proteins in cancerPreprint
Lee, K., Byun, K., Hong, W.-P., Chuang, H., Pack, C., Bayarsaikhan, E., Paek, S. H., Kim, H., Shin, H. Y., Ideker, T. E., et al. (2013) · Genome Research · doi:10.1101/gr.155499.113 · Cited by 56
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model
Sawa, M., Overk, C., Becker, A., Derse, D., Albay, R., Weldy, K., Salehi, A., Beach, T. G., Doran, E., Head, E., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12463 · Cited by 54
Rodríguez‐Sureda, V., García, Á. V., Sánchez, O., Audı́, L., & Domı́nguez, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/509241 · Cited by 55
Gene expression analysis of induced pluripotent stem cells from aneuploid chromosomal syndromes
Zhang, R., Hao, L., Wang, L., Chen, M., Li, W., Li, R., Yu, J. M., Xiao, J., & Wu, J. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-s5-s8 · Cited by 53
Rajpathak, S. N., Vellarikkal, S. K., Patowary, A., Scaria, V., Sivasubbu, S., & Deobagkar, D. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100076 · Cited by 51
Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19
Toma, I. D., & Dierssen, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-81451-w · Cited by 50
CRTC1 gene is differentially methylated in the human hippocampus in Alzheimer’s disease
Mendióroz, M., Celarain, N., Altuna, M., de Gordoa, J. S., Zelaya, M. V., Roldán, M., Rubio, I., Larumbe, R., Erro, M. E., Méndez-López, I., et al. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0183-0 · Cited by 51
Amniotic Fluid Proteome Analysis from Down Syndrome Pregnancies for Biomarker Discovery
Cho, C.-K. J., Smith, C. R., & Diamandis, E. P. (2010) · Journal of Proteome Research · doi:10.1021/pr100088k · Cited by 50
Perez, S. E., Miguel, J. C., He, B., Malek‐Ahmadi, M. H., Abrahamson, E. E., Ikonomović, M. D., Lott, I. T., Doran, E. W., Alldred, M. J., Ginsberg, S. D., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01965-6 · Cited by 48
Altered expression of Notch1 in Alzheimer's disease
Cho, S.-J., Yun, S., Jo, C., Jeong, J., Park, M. H., Han, C., & Koh, Y. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224941 · Cited by 49
Ponroy Bally, B., Farmer, W. T., Jones, E. V., Jessa, S., Kacerovsky, J. B., Mayran, A., Peng, H., Lefebvre, J. L., Drouin, J., Hayer, A., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa003 · Cited by 49
Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome
Mok, K. Y., Jones, E. L., Hanney, M., Harold, D., Sims, R., Williams, J., Ballard, C., & Hardy, J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.022 · Cited by 48
Schaevitz, L. R., Berger-Sweeney, J. E., & Ricceri, L. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.04.007 · Cited by 50
Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
Stringer, M., Goodlett, C. R., & Roper, R. J. (2017) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.334 · Cited by 45
Stem and progenitor cell dysfunction in human trisomies
Liu, B., Filippi, S., Roy, A., & Roberts, I. A. G. (2014) · EMBO Reports · doi:10.15252/embr.201439583 · Cited by 44
Inherent variability of cancer-specific aneuploidy generates metastases
Bloomfield, M., & DUESBERG, P. H. (2016) · Molecular Cytogenetics · doi:10.1186/s13039-016-0297-x · Cited by 42
Zhang, Y., Wu, K., Su, W., Zhang, D., Wang, P., Qiao, X., Yao, Q., Yuan, Z., Yao, Y., Liu, G., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0681-17.2017 · Cited by 43
Regulation of global gene expression and cell proliferation by APP
Wu, Y., Zhang, S., Xu, Q., Zou, H., Zhou, W., Cai, F., Li, T., & Song, W. (2016) · Scientific Reports · doi:10.1038/srep22460 · Cited by 41
Duchon, A., Moreno, M. D. M. M., Lorenzo, S. M., de Souza, M. P. S., Chevalier, C., Nalesso, V., Méziane, H., de Sousa, P. L., Noblet, V., Armspach, J., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab012 · Cited by 42
Ahmed, M. M., Johnson, N. R., Boyd, T. D., Coughlan, C. M., Chial, H. J., & Potter, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.718426 · Cited by 42
Rheinbay, E., Nielsen, M. M., Abascal, F., Tiao, G., Hornshøj, H., Hess, J. M., Pedersen, R. I., Feuerbach, L., Sabarinathan, R., Madsen, T. L., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/237313 · Cited by 40
Leal, M. C., Surace, E., Holgado, M., Ferrari, C., Tarelli, R., Pitossi, F., Wisniewski, T., Castaño, E., & Morelli, L. (2011) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamcr.2011.09.014 · Cited by 41
Mégarbané, A., Noguier, F., Stora, S., Manchon, L., Mircher, C., Bruno, R., Dorison, N., Pierrat, F., Rethoré, M. O., Trentin, B., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.24 · Cited by 38
Cheng, J. X., Scala, F., Blanco, F. A., Niu, S., Firozi, K., Keehan, L. A., Mulherkar, S. A., Froudarakis, E., Li, L., Duman, J. G., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.3271-17.2020 · Cited by 33
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Macciardi, F., Giulia Bacalini, M., Miramontes, R., Boattini, A., Taccioli, C., Modenini, G., Malhas, R., Anderlucci, L., Gusev, Y., Gross, T. J., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00580-w · Cited by 37
Astrocytes in Down Syndrome Across the Lifespan
Ponroy Bally, B., & Murai, K. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.702685 · Cited by 35
Alldred, M. J., Chao, H. M., Lee, S. H., Beilin, J., Powers, B. E., Petkova, E., Strupp, B. J., & Ginsberg, S. D. (2018) · Hippocampus · doi:10.1002/hipo.22832 · Cited by 35
Reducing Gabaergic Inhibition Restores Cognitive Functions in a Mouse Model of Down Syndrome
Potier, M.-C., Braudeau, J., Dauphinot, L., & Delatour, B. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660185 · Cited by 34
Sylvester, T. P., Hjelmen, C. E., Hanrahan, S. J., Lenhart, P. A., Johnston, J. S., & Blackmon, H. (2020) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2020.1388 · Cited by 34
Gene expression variation increase in trisomy 21 tissues
Chou, C., Liu, L.-Y. D., Chen, C., Tsai, C. H., Hwa, H., Chang, L. Y., Lin, Y. S., & Hsieh, F. J. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9121-1 · Cited by 36
Laan, L., Klar, J., Sobol, M., Hoeber, J., Shahsavani, M., Kele, M., Fatima, A., Zakaria, M., Annerén, G., Falk, A., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-019-0803-1 · Cited by 33
Cellular senescence and premature aging in Down Syndrome
Peng, L., Baradar, A. A., Aguado, J., & Wolvetang, E. J. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111824 · Cited by 36
Down syndrome is an oxidative phosphorylation disorder
Bayona‐Bafaluy, M. P., Garrido-Pérez, N., Meade, P., Iglesias, E., Jiménez-Salvador, I., Montoya, J., Martínez‐Cué, C., & Ruiz‐Pesini, E. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101871 · Cited by 33
Parrini, M., Naskar, S., Alberti, M., Colombi, I., Morelli, G., Rocchi, A., Nanni, M., Piccardi, F., Charles, S., Ronzitti, G., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.05.023 · Cited by 34
A cross-laboratory comparison of expression profiling data from normal human postmortem brain
Mistry, M., & Pavlidis, P. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.016 · Cited by 32
Lim, S.-Y., Hwang, S., Yu, J. H., Lim, J. W., & Kim, H. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600530 · Cited by 33
Guedj, F., Pennings, J., Ferrés, M., Graham, L. C., Wick, H. C., Miczek, K. A., Slonim, D., & Bianchi, D. W. (2015) · American Journal of Medical Genetics. Part A · doi:10.1002/ajmg.a.37156 · Cited by 30
Granese, B., Scala, I., Spatuzza, C., Valentino, A., Coletta, M., Vacca, R. A., Luca, P. D., & Andria, G. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-24 · Cited by 32
HYPK coordinates degradation of polyneddylated proteins by autophagy
Ghosh, D. K., & Ranjan, A. (2021) · Autophagy · doi:10.1080/15548627.2021.1997053 · Cited by 31
Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome
Lim, J. H., Kim, D. J., Lee, D. E., Han, J. Y., Chung, J. H., Ahn, H. K., Lee, S. W., Lim, D., Lee, Y. S., Park, S. Y., et al. (2015) · Placenta · doi:10.1016/j.placenta.2014.12.020 · Cited by 30
Créau, N. (2012) · Neural Plasticity · doi:10.1155/2012/171639 · Cited by 30
Cho, C.-K. J., Drabovich, A. P., Karagiannis, G. S., Martínez‐Morillo, E., Dason, S., Dimitromanolakis, A., & Diamandis, E. P. (2013) · Clinical Proteomics · doi:10.1186/1559-0275-10-2 · Cited by 30
Qi, H., Xuan, Z., Du, Y., Cai, L., Zhang, H., Wen, X., Kong, X., Yang, K., Mi, Y., Fu, X., et al. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.03.008 · Cited by 31
Bioinformatics analysis of biomarkers and transcriptional factor motifs in Down syndrome
Kong, X., Liu, N., & Xu, X. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20143792 · Cited by 28
Patterns of Aneuploidy and Signaling Consequences in Cancer
Zhakula-Kostadinova, N., & Taylor, A. M. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0169 · Cited by 31
Altered Expression of Immune-Related Genes in Children with Down Syndrome
Zampieri, B. L., Biselli, J. M., de Souza, J. E. S., Bürger, M. C., Silva, W. A., Goloni‐Bertollo, E. M., & Pavarino, É. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107218 · Cited by 29
A quantitative transcriptome reference map of the normal human brain
Caracausi, M., Vitale, L., Pelleri, M. C., Piovesan, A., Bruno, S., & Strippoli, P. (2014) · Neurogenetics · doi:10.1007/s10048-014-0419-8 · Cited by 27
Spatial organization of chromosome territories in the interphase nucleus of trisomy 21 cells
Kemeny, S., Tatout, C., Salaün, G., Pebrel‐Richard, C., Goumy, C., Ollier, N., Maurin, E., Pereira, B., Vago, P., & Gouas, L. (2017) · Chromosoma · doi:10.1007/s00412-017-0653-6 · Cited by 30
Sheng, L., Leshchyns’ka, I., & Sytnyk, V. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy041 · Cited by 27
Brain Phenotype of Transgenic Mice Overexpressing Cystathionine β-Synthase
Régnier, V., Billard, J., Gupta, S., Potier, B., Woerner, S., Paly, E., Ledru, A., David, S., Luilier, S., Bizot, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029056 · Cited by 30
Genome-Wide Expression Analysis in Down Syndrome: Insight into Immunodeficiency
Li, C. V., Jin, L., Bai, Y., Chen, Q., Fu, L., Yang, M., Xiao, H., Zhao, G., & Wang, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049130 · Cited by 27
Metadata
- Authors
- Lockstone, H. E., Harris, L. W., Swatton, J. E., Wayland, M. T., Holland, A. J., & Bahn, S.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Bahn, S.
- Venue
- Genomics
- Publisher
- Elsevier BV
- Published
- 2007-12
- Volume
- 90
- Issue
- 6
- Pages
- 647-660
- ISSN
- 0888-7543 (ISSN-L)
- OpenAlex
- W2010597204
- Cited by
- 240
- References
- 76
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 10 · 2023: 8 · 2022: 13 · 2021: 20 · 2020: 12 · 2019: 14 · 2018: 15 · 2017: 14 · 2016: 15 · 2015: 11 · 2014: 16 · 2013: 15 · 2012: 19
- FWCI
- 9.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Genomics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stanley Medical Research Institute
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- Down syndrome, dorsolateral prefrontal cortex, gene expression profiling, APP processing, Notch signaling, Dlx genes, lipid transport, cell proliferation, cytoskeleton regulation, vesicle trafficking, immune response, oxidative stress response
- MeSH terms
- Adult, Aged, Alzheimer Disease, Chromosomes, Human, Pair 21, Down Syndrome, Female, Fetus, Humans, Male, Middle Aged, Receptors, Cell Surface, Up-Regulation, Case-Control Studies, Polymerase Chain Reaction, Amyloid beta-Protein Precursor, Prefrontal Cortex, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Databases, Genetic, Proteomics, Protease Nexins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
